Log in to save to my catalogue

Telbivudine for renal transplant recipients with chronic hepatitis B infection: a randomized control...

Telbivudine for renal transplant recipients with chronic hepatitis B infection: a randomized control...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2392895178

Telbivudine for renal transplant recipients with chronic hepatitis B infection: a randomized controlled trial with early termination

About this item

Full title

Telbivudine for renal transplant recipients with chronic hepatitis B infection: a randomized controlled trial with early termination

Publisher

Singapore: Springer Singapore

Journal title

Clinical and experimental nephrology, 2020-05, Vol.24 (5), p.474-482

Language

English

Formats

Publication information

Publisher

Singapore: Springer Singapore

More information

Scope and Contents

Contents

Background
The aim of this study was to analyze changes in renal function in HBsAg-positive renal transplant recipients receiving lamivudine who did or did not switch to telbivudine.
Methods
In this prospective randomized clinical trial (RCT), HBsAg-positive renal transplant recipients who had received lamivudine prophylaxis for at least 6...

Alternative Titles

Full title

Telbivudine for renal transplant recipients with chronic hepatitis B infection: a randomized controlled trial with early termination

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2392895178

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2392895178

Other Identifiers

ISSN

1342-1751

E-ISSN

1437-7799

DOI

10.1007/s10157-020-01850-7

How to access this item